Submit Deal

VALEANT PHARMACEUTICALS

Summary

Valeant Pharmaceuticals is a global pharmaceutical company.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 31.62 B

Avg. Deal Size£ 15.81 B

Market Context

Sort

dla piper

HQ - London

legal advisors (1)

1 Shared Deal

1 Opposite

£ 667 M

Total Value

hogan lovells

HQ - London

legal advisors (1)

1 Shared Deal

1 For

£ 667 M

Total Value

latham & watkins

HQ - New York, United States

legal advisors (1)

1 Shared Deal

1 Opposite

£ 30.95 B

Total Value

richards layton and finger

HQ - Wilmington

legal advisors (1)

1 Shared Deal

1 Opposite

£ 30.95 B

Total Value

bank of america

HQ - Charlotte

financial advisors (1)

1 Shared Deal

1 Opposite

£ 30.95 B

Total Value

goldman sachs

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 30.95 B

Total Value

joele frank

HQ - New York

pr advisors (1)

1 Shared Deal

1 Opposite

£ 30.95 B

Total Value

barclays

HQ - London

debt providers (1)

financial advisors (1)

2 Shared Deals

2 For

£ 61.90 B

Total Value

rbc capital markets

HQ - Toronto

debt providers (1)

financial advisors (1)

2 Shared Deals

2 For

£ 61.90 B

Total Value

sard verbinnen & co

pr advisors (1)

1 Shared Deal

1 For

£ 30.95 B

Total Value

osler hoskin & harcourt

HQ - Toronto

legal advisors (1)

1 Shared Deal

1 For

£ 30.95 B

Total Value

davies ward phillips & vineberg

HQ - Toronto

legal advisors (1)

1 Shared Deal

1 For

£ 30.95 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy